InCode BioPharmaceutics, Inc.
RECENT PUBLICATIONS
InCode BioPharmaceutics, Inc

Abstracts presented at the XXII International Complement Workshop, Basel, Switzerland, 28 September - 2 October 2008

D.C. Fritzinger, B.E. Hew, J.Q. Lee et al. (2008). Molecular Immunology 45:4095. Human C3-cobra venom factor hybrid proteins for the therapeutic complement depletion: In vivo activity and lack of toxicity in primates.

D.C. Friztinger, V. Ferreira, B. Hew, et al. Molecular Immunology 45:4177. A novel concept for the treatment of paroxysmal noctural hemoglobinuria (PNH): Complement depletion with a human C3 derivative with cobra venom factor-like activity prevents lysis of PNH erythrocytes.

B. Hew, J. Lee, J. Awakuni et al. Molecular Immunology 45:4120. Human C3/cobra venom factor hybrid proteins for therapeutic complement depletion: Fine mapping of structure/function relationships.


Abstract to be presented at the 50th Annual Meeting of the American Society for Hematology, December 6-9, 2008

http://ash.confex.com/ash/2008/webprogram/Paper13711.html